The effectiveness of tirzepatide for treating obesity is being evaluated in the SURMOUNT series of phase 3 RCTs, which, for the first time, demonstrated average weight reductions exceeding 20% with pharmacotherapy [23]
The diabetes drug Ozempic, known generically as semaglutide, is a GLP-1 receptor agonist developed by Novo Nordisk for type 2 diabetes management
Depression is linked to hyperglycaemia via suboptimal diabetes self-ma nagement: a cross-sectional mediation analysis
Therefore, surgeons and anesthesiologists must be diligent in discussing expectations for the postoperative period
The personalized medical weight loss options offered by our providers may include GLP-1 medications such as Semaglutide or Liraglutide, depending on individual needs and availability
"Lilly's Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges." December 12, 2025